Joe Fiandra Access to Home Infusion Act of 2025

United States119th CongressHR-4993House of Representatives
Updated: Dec 10, 2025

Summary

This bill, known as the "Joe Fiandra Access to Home Infusion Act of 2025," aims to expand Medicare coverage for external infusion pumps and associated non-self-administrable home infusion drugs and supplies. It amends the Social Security Act to ensure these items are covered for home use, even if they don't strictly meet existing durable medical equipment requirements, provided specific conditions are met. For coverage, the drug's FDA-approved prescribing information must require administration by or under the supervision of a healthcare professional . Additionally, a qualified home infusion therapy supplier must administer or supervise the drug in the patient's home, and the drug must be prescribed for infusion at least 12 times annually, either intravenously/subcutaneously or at rates necessitating an external infusion pump. The bill further directs the Secretary of Health and Human Services to ensure patients receive clear notifications about the cost sharing associated with electing home infusion therapy, allowing them to compare it with costs in other applicable care settings under Medicare.

Bill texts

Available versions
Introduced (House)View official text

1 version available

All available records shown.

Timeline

  1. Introduced in House

  2. Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    House of Representatives

  3. Committee Consideration and Mark-up Session Held

    House of Representatives

  4. Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 41 - 0.

    House of Representatives

All available records shown.